Loading…
Tenet Healthcare Corporation is projected to rise to $203.68 by 2027, a +12% move from its current price of $181.06. THC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $177.56 | $181.09 | $184.69 | +0.02% |
| May 30 | $176.15 | $181.12 | $186.23 | +0.03% |
| May 31 | $175.08 | $181.14 | $187.42 | +0.05% |
| Jun 1 | $174.18 | $181.17 | $188.44 | +0.06% |
| Jun 2 | $173.40 | $181.20 | $189.35 | +0.08% |
| Jun 3 | $172.70 | $181.23 | $190.18 | +0.09% |
| Jun 4 | $172.06 | $181.26 | $190.94 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $172.06 | $181.26 | $190.94 | +0.11% |
| Week 2 | $168.58 | $181.46 | $195.32 | +0.22% |
| Week 3 | $165.99 | $181.66 | $198.80 | +0.33% |
| Week 4 | $163.87 | $181.85 | $201.81 | +0.44% |
| Week 5 | $162.05 | $182.05 | $204.53 | +0.55% |
| Week 6 | $160.43 | $182.25 | $207.04 | +0.66% |
| Week 7 | $158.98 | $182.45 | $209.39 | +0.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals.
Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Tenet Healthcare Corporation (THC) is a healthcare services company. The stock trades at $173.78 and has a market capitalization of $14.97B, with a rank of 701. The current price sits within a forecasted trajectory that envisions a path from the current level to higher prices in coming years.
The market is positioned for a multi-year uptrend according to the year-by-year forecast.
A major floor 11.8% below — a decisive break under it would weaken the trend.
The nearest floor, 4.0% below — buyers have tended to step in here.
The nearest ceiling, 9.7% above — a clean break opens room to run.
A major ceiling 35.2% above — clearing it would confirm fresh momentum.
Key THC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of THC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $179.33 | Buy | $180.70 | Buy |
| MA 10 | $187.16 | Sell | $184.01 | Sell |
| MA 20 | $187.54 | Sell | $186.92 | Sell |
| MA 50 | $191.40 | Sell | $193.06 | Sell |
| MA 100 | $202.34 | Sell | $197.05 | Sell |
| MA 200 | $199.34 | Sell | $192.67 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.44 | Neutral |
| Stoch RSI (14) | 38.54 | Neutral |
| CCI (20) | -65.44 | Neutral |
| Williams %R (14) | -70.61 | Info |
| MACD (12,26,9) | -1.25 | Sell |
| ROC (12) | -4.90 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 29.39 | Neutral |
| TRIX (15) | -0.14 | Sell |
| Awesome (5,34) | -9.49 | Sell |
| Ultimate (7,14,28) | 30.20 | Neutral |
| Momentum (10) | -14.82 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 172.47 | Buy |
| ADX (14) | 16.10 | Neutral |
| ATR (14) | 3.77 | Info |
The 30-day technical picture is bearish, with RSI14 at 30. The stock trades around a support level of $173.78 and faces resistance at $198.55. The SMA50 is $193.19 and the SMA200 is $199.20, indicating downward pressure near key moving averages. The 30-day range spans from $152.39 to $198.18, and annualized volatility stands at 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $173.78 | $181.06 | $227.63 | 0% | Neutral | |
| $165.91 | $203.68 | $262.06 | +12% | Neutral | |
| $174.12 | $217.84 | $287.90 | +20% | Bullish | |
| $197.82 | $251.43 | $339.47 | +39% | Bullish | |
| $234.61 | $302.36 | $415.74 | +67% | Bullish | |
| $236.60 | $308.79 | $431.44 | +71% | Bullish | |
| $251.36 | $331.91 | $470.51 | +83% | Bullish | |
| $270.00 | $360.44 | $517.73 | +99% | Bullish | |
| $259.89 | $350.56 | $509.71 | +94% | Bullish | |
| $293.17 | $399.36 | $587.30 | +121% | Bullish | |
| $390.79 | $556.38 | $858.56 | +207% | Bullish | |
| $749.90 | $1,149.40 | $1,904.91 | +535% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $173.78 | $181.06 | $212.55 | +0.00% |
| June 2026 | $158.77 | $185.34 | $220.64 | +2.36% |
| July 2026 | $156.39 | $183.66 | $220.80 | -0.91% |
| August 2026 | $155.28 | $183.22 | $221.94 | -0.24% |
| September 2026 | $158.32 | $187.53 | $228.57 | +2.35% |
| October 2026 | $158.02 | $187.83 | $230.23 | +0.16% |
| November 2026 | $153.84 | $183.44 | $225.95 | -2.34% |
| December 2026 | $153.81 | $183.95 | $227.63 | +0.28% |
Click any year to see its month-by-month THC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Tenet Healthcare Corporation's 2026 outlook centres on $181.06, within a $173.78 to $227.63 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, THC could reach as high as $262.06, with a base case around $203.68 and support toward $165.91 — roughly +12% from $181.06. A consolidation phase looks the most probable path here.
Expect THC to range from $174.12 to $287.90 through 2028. The $217.84 average target implies a +20% move from current prices. That is up +7% on the projected 2027 average. Momentum favours further upside here.
The THC price prediction for 2029 points to an average of $251.43 (low $197.82, high $339.47) — a potential gain of +39% on today's $181.06. Buyers look set to stay in control over this stretch.
In 2030, THC is projected to trade between $234.61 and $415.74, averaging $302.36 — a potential gain of +67% from today's $181.06. That is up +20% on the projected 2029 average. Momentum favours further upside here.
Tenet Healthcare Corporation's 2031 outlook centres on $308.79, within a $236.60 to $431.44 range. That is up +2% on the projected 2030 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, THC could reach as high as $470.51, with a base case around $331.91 and support toward $251.36 — roughly +83% from $181.06. Momentum favours further upside here.
Expect THC to range from $270.00 to $517.73 through 2033. The $360.44 average target implies a +99% move from current prices. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The THC price prediction for 2034 points to an average of $350.56 (low $259.89, high $509.71) — a potential gain of +94% on today's $181.06. Momentum favours further upside here.
In 2035, THC is projected to trade between $293.17 and $587.30, averaging $399.36 — a potential gain of +121% from today's $181.06. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Tenet Healthcare Corporation's 2040 outlook centres on $556.38, within a $390.79 to $858.56 range. That is up +39% on the projected 2035 average. That marks a +207% change versus current levels. Momentum favours further upside here.
By 2050, THC could reach as high as $1,904.91, with a base case around $1,149.40 and support toward $749.90 — roughly +535% from $181.06. Buyers look set to stay in control over this stretch.
Investing $1,000 in THC today (≈ 5.523031 THC) could be worth
$6,348.17
+$5,348.17 (+535%) by 2050 · US Dollar
Based on the average projected THC price of $1,149.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in THCwould be worth at today's price.
$1,000 invested in THC on May 27, 2025 (≈ 6.056935 THC) would be worth
$1,096.67
+$96.67 (+9.7%) today · 1.10× · US Dollar
Based on a THC entry price of $165.1 vs. today's $181.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $187.41 | $966.12 | -3.4% |
| 1 month ago | $185.53 | $975.91 | -2.4% |
| 3 months ago | $239.67 | $755.46 | -24.5% |
| 6 months ago | $216.84 | $834.99 | -16.5% |
| 1 year ago | $165.1 | $1,096.67 | +9.7% |
| All time (5.0y) ago | $68.51 | $2,642.83 | +164.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our THC forecast.
Our base-case forecast reaches $360.00 around 2033.
Implied market cap at $360.00: $31.01B
Over the multi-year horizon, the forecast shows a bullish trajectory with rising averages and substantial upside by 2050. In 2026 the min and avg are both $173.78, with a max of $219.00 and an ROI of 0% and neutral sentiment. By 2030 the avg is $283.95 with a max of $391.31 and an ROI of 63.4% in a bullish context, while the 2040 forecast shows an avg of $512.76 and a max of $793.87 with a 195.1% ROI.
By 2050 the avg climbs to $1,057.77 and a max of $1,759.98, delivering an estimated 508.7% ROI in a bullish setting. The year-by-year path includes consistent upside from 2029 onward, reaching higher price levels as indicated by the series of rising averages and escalating max values, though the path remains contingent on market dynamics and is not a guarantee.
Tap a question to reveal the answer.
2030: min $219.95, avg $283.95, max $391.31; ROI 63.4%; sentiment BULLISH.
The forecast shows a long-term bullish path with positive ROIs—63.4% in 2030, 195.1% in 2040, and 508.7% in 2050—though early years are neutral to cautious and outcomes are not guaranteed.
Yes. The 2050 forecast lists an average of $1,057.77 and a max of $1,759.98, indicating the possibility of price levels above $1,000 by 2050.
Current price: $173.78. Market cap: $14.97B.
30-day range: low $152.39, high $198.18.
Tenet Healthcare Corporation Community Discussion
0Share your Tenet Healthcare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.